Green Pine Capital Partners
This round of financing was led by CDH VGC (CDH Venture and Growth Capital). Existing investors, GL Ventures, continued to make additional investments.
VisionX, a company dedicated to the research and development of a full set of innovative solutions for medical devices in the field of ophthalmic ophthalmology, has recently completed its Series A financing round, and has secured Series A+ round, with an overall financing amount of more than 100 million yuan.
Synthetic biotechnology company Bluepha has recently received tens of millions of yuan in its Series A+ financing round, and the investor was Green Pine Capital Partners.